| Title of Process/ Know-how/ Product/Design/Equipment
Preparation of ultrapure salt meeting Pharmaceutical-grade specifications.
IPR Status & Details:
In process
Application/Uses/Problem being addressed
The Indian demand for ultrapure salt of pharmaceutical applications, currently worth US$ 6.5 M, is projected to see a growth of 8.5% through to 2028 to reach 38,000 metric tons. As there is, no major manufacturer of pharmaceutical sodium chloride in India, and several small manufacturers may not meet the projected demand, it is necessary to establish a process for large volume production in continuous basis. Considering the growing demand, lowest market price (363 US$ /Ton) after China and 3rd largest salt producing country in the world, India can play a global role in this sector.
Salient Technical Features including Competing Features/ Impact
TRL Level & Scale of Development:- TRL 5 TRL Reference
Business scope & opportunity (in terms of scale, cost, market etc.)
The process has several advantages over existing processes. Hence, this process has huge business scope considering the cost and easiness to scale-up.
Environmental Considerations
The process is environmental friendly. The solid by-product Magnesium hydroxide along with other metal hydroxides can be used for derive other magnesia chemicals.
Status of Licensing:
Ready for licensing
Status of Commercialization:
Not applicable
Major Raw Materials Needed
Raw NaCl, NaOH/CaO/Na2CO3
Major Plant Equipment and Machinery Required
Brine tank with agitator, Nutsche filter, Single/Multi-stage evaporator, Ultrafiltration unit, Centrifuge, process pump, Dryer
Techno-Economics
Production cost of the salt will be around ₹13-14/kg.
Technology Package
Technical specification of each component, design drawing & layout, installation & commissioning, demonstration, basic training for the process (SOP).